Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| SIT INVESTMENT ASSOCIATES INC | SRV NXG Cushing Midstream Energy Fund | 13G/A | 0.81% | Apr 4, 2024 | 2y |
| Saba Capital Management, L.P. | NPCT Nuveen Core Plus Impact Fund | 13D/A | 11.35% | Apr 3, 2024 | 2y |
| ORBIMED ADVISORS LLC | ELVN Enliven Therapeutics, Inc. | 13D/A | 19.2% | Apr 2, 2024 | 2y |
| Apollo Management Holdings GP, LLC | SNX Td Synnex Corp | 13D/A | 6.1% | Apr 2, 2024 | 2y |
| Bleichroeder LP | INVE INVE Technologies, Inc. | 13D/A | 19.9% | Apr 2, 2024 | 2y |
| Saba Capital Management, L.P. | NOM NUVEEN MISSOURI QUALITY MUNICIPAL INCOME FUND | 13D | 5.35% | Apr 2, 2024 | 2y |
| Cano Health, Inc. | MSPR MSP Recovery, Inc. | 13D/A | 0% | Apr 2, 2024 | 2y |
| David Shan | MAMO Massimo Group | 13G | 77.7% | Apr 1, 2024 | 2y |
| Gary Bowman | BWMN Bowman Consulting Group Ltd. | 13D/A | 14.43% | Apr 1, 2024 | 2y |
| Farhad Fred Ebrahimi | SSYS Stratasys Ltd. | 13D/A | 4.9% | Apr 1, 2024 | 2y |
| Standard General L.P. | MDIA Mediaco Holding Inc. | 13D/A | 95.2% | Apr 1, 2024 | 2y |
| BAILLIE GIFFORD & CO | NIO NIO Inc. | 13G/A | 0.98% | Mar 29, 2024 | 2y |
| BAILLIE GIFFORD & CO | MBLY Mobileye Global Inc. | 13G/A | 16.87% | Mar 29, 2024 | 2y |
| WESTFIELD CAPITAL MANAGEMENT CO LP | MURA Mural Oncology plc Ordinary Shares | 13G/A | 9.15% | Mar 29, 2024 | 2y |
| CVI Investments, Inc. | RNLXY Renalytix plc | 13G | 6.9% | Mar 28, 2024 | 2y |
| ARC Global Investments II LLC | DJT Trump Media & Technology Group Corp. | 13G | 9.8% | Mar 25, 2024 | 2y |
| Anders Hove | QTTB Q32 Bio Inc. | 13D | 6.7% | Mar 25, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | DYN Dyne Therapeutics, Inc. | 13G | 6.4% | Mar 25, 2024 | 2y |
| Encompass Capital Advisors LLC | GFR Greenfire Resources Ltd. | 13G | 5.24% | Mar 25, 2024 | 2y |
| Deerfield Management Company, L.P. | VTYX Ventyx Biosciences, Inc. Common Stock | 13G | 5.03% | Mar 15, 2024 | 2y |
| Greater Miami Jewish Federation, Inc. | RDVT Red Violet, Inc. | 13G/A | 0% | Apr 3, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | PPT Franklin Premier Income Trust | 13D/A | 21.23% | Apr 3, 2024 | 2y |
| Ariel Emanuel | EDR Endeavor Group Holdings, Inc. | 13D/A | 11.9% | Apr 2, 2024 | 2y |
| HL Voting Trust | HLI Houlihan Lokey, Inc. | 13D/A | 25.1% | Apr 2, 2024 | 2y |
| Kimmeridge Energy Management Company, LLC | CIVI Civitas Resources, Inc. | 13D/A | 4.1% | Apr 2, 2024 | 2y |
| Libman Family Holdings, LLC | FOA Finance of America Companies Inc. | 13D/A | 48.6% | Apr 1, 2024 | 2y |
| Independence Energy Aggregator L.P. | CRGY Crescent Energy Co | 13D/A | 21.1% | Apr 1, 2024 | 2y |
| Magnetar Financial LLC | DSKE Daseke, Inc. Common Stock | 13D/A | 0% | Apr 1, 2024 | 2y |
| Jermyn Street Associates LLC | NOTVQ Inotiv, Inc. | 13D/A | 4.89% | Apr 1, 2024 | 2y |
| Blackstone Holdings II L.P. | FOA Finance of America Companies Inc. | 13D/A | 55.4% | Apr 1, 2024 | 2y |
| BPP HoldCo LLC | CPE Callon Petroleum Company | 13D/A | 0% | Apr 1, 2024 | 2y |
| Bellevue Capital Partners, LLC | NYC American Strategic Investment Co. | 13D/A | 50% | Apr 1, 2024 | 2y |
| Insight Venture Partners X, L.P. | NCNO nCino, Inc. | 13D/A | 29.8% | Apr 1, 2024 | 2y |
| Andrew Africk | CVV Cvd Equipment Corp | 13G/A | 18.97% | Apr 1, 2024 | 2y |
| Altamont Pharmaceutical Holdings, LLC | GRTXD Galera Therapeutics, Inc. | 13G/A | 0% | Apr 1, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | RYTM Rhythm Pharmaceuticals, Inc. | 13D/A | 5.4% | Apr 1, 2024 | 2y |
| REH Company | DINO HF Sinclair Corp | 13D/A | 9% | Apr 1, 2024 | 2y |
| Waha LATAM Investments Limited | DESP Despegar.com, Corp. | 13D/A | 0% | Apr 1, 2024 | 2y |
| Madison Square Garden Entertainment Corp. | TSQ Townsquare Media, Inc. | 13D/A | 1.2% | Apr 1, 2024 | 2y |
| WILLIS CHARLES F IV | WLFC Willis Lease Finance Corp | 13D/A | 44.18% | Apr 1, 2024 | 2y |
| Stachowiak Raymond C | AMS American Shared Hospital Services | 13D/A | 21.9% | Apr 1, 2024 | 2y |
| Ninety One UK Ltd | VSTA Vasta Platform Limited Class A Ordinary Shares | 13G | 5.8% | Mar 31, 2024 | 2y |
| Vellar Opportunities Fund Master, Ltd. | OIO OIO Group | 13G/A | 0% | Mar 31, 2024 | 2y |
| Gregory George | MESO Mesoblast Ltd | 13G/A | 12.59% | Mar 28, 2024 | 2y |
| IndexIQ Advisors LLC | UUP Invesco DB US Dollar Index Bullish Fund | 13G | 5.56% | Mar 28, 2024 | 2y |
| JREP I Logistics Acquisition, LP | LPA Logistic Properties of the Americas | 13D | 83% | Mar 27, 2024 | 2y |
| HC PropTech Partners III LLC | LPA Logistic Properties of the Americas | 13G | 6.7% | Mar 27, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | NARI Inari Medical, Inc. Common Stock | 13G | 3.8% | Mar 27, 2024 | 2y |
| ATW Growth Opportunities SPV, LLC | KITT Nauticus Robotics, Inc. | 13G | 9.9% | Mar 26, 2024 | 2y |
| Lara Sullivan | PYXS Pyxis Oncology, Inc. | 13D/A | 8.89% | Mar 26, 2024 | 2y |